Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option
Status:
COMPLETED
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
This randomized controlled study aims to evaluate the effectiveness and safety of the pharmaceutical extract EPs® 7630 from P.sidoides in treating hand, foot, and mouth disease in children. The study will investigate the impact of EPs® 7630 on the severity of the disease over a specific period and its effects on hospitalization rates and potential complications. This research aims to contribute to the treatment of hand, foot, and mouth disease in children.